全球失眠市场 - 2029 年行业趋势及预测

市场分析与洞察全球失眠市场

失眠市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，该市场将以 5.4% 的复合年增长率增长。推动该市场增长的因素是新兴市场和对研发的大量投资。

失眠症是一种睡眠障碍，患者难以入睡或保持睡眠。其症状包括精力不足、白天嗜睡、抑郁和易怒。这是一种非常常见的疾病，影响着全世界数百万人。昼夜节律紊乱、慢性疼痛、甲状腺功能亢进、更年期、心理压力和其他疾病都会导致失眠。此外，过量使用咖啡因、酒精和尼古丁等药物也可能导致失眠。睡眠实验室使用各种诊断设备来诊断这种疾病。

压力水平上升、市场上出现专利分子、临床研发中的潜在药物、技术先进的医疗设备的引入以及老年人口的增长都是影响失眠治疗市场增长的因素。人们越来越意识到睡眠不足对日常生活的影响，预计各种失眠治疗的采用率将提高，从而导致失眠治疗市场的收入增长。

Other factors, such as side effects from certain over-the-counter and prescription medications, arthritis, and excessive use of media devices before bed, are increasing the number of people suffering from insomnia, boosting market growth prospects. Furthermore, the rise in psychological disorders and the ever-increasing noise levels in cities will drive the insomnia treatment market during the forecast period. Furthermore, emerging markets and significant investment in research and development are driving this market's growth.

However, misconceptions about the seriousness of insomnia, as well as patient non-adherence to treatment, are among the factors expected to limit market growth over the forecast period. Dearth of skilled medical professionals and lack of a strong healthcare infrastructure in the backward economies are further derailing the market growth rate

This insomnia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the insomnia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Insomnia Market Scope and Market Size

The insomnia market is segmented on the basis of therapy type, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of therapy type, the global insomnia market is segmented into non-pharmacological and pharmacological therapy
• Based on drug class, the global insomnia market is segmented into melatonin antagonist, antidepressants, benzodiazepines, non-benzodiazepines and others.
• Route of administration segment for global insomnia market is categorized into oral, parenteral and others.
• On the basis of end-users, the global insomnia market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the global insomnia market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Insomnia Market Country Level Analysis

Insomnia market is analysed and market size information is provided by the country, therapy type, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the insomnia market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the global insomnia market and will flourish its dominance over the forecast period because of global leaders in research and development activities, an established approval process framework, an increase in the number of FDA-approved drugs and rise in the patient suffering from mental illness. Asia-Pacific is projected to score the highest growth rate owing to the developing healthcare facilities, a large number of generic manufacturers, and an increase in government initiatives and specialist communities.

The country section of the insomnia market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Insomnia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to insomnia market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the insomnia market in the growth period.

Competitive Landscape and Insomnia Market Share Analysis

失眠市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对全球失眠市场研究的关注有关。

失眠市场的一些主要参与者包括武田药品工业株式会社、雷迪博士实验室有限公司、辉瑞公司、Endo International plc、Teva Pharmaceutical Industries Ltd.、Sun Pharmaceutical Industries Ltd.、Mylan NV、诺华公司、Lupin.、Cipla Inc.、Aurobindo Pharma.、Torrent Pharmaceuticals Ltd、Alvogen.、默克夏普和多姆公司、Apotex Inc.、Zydus Cadila.、Saneca Pharmaceuticals、Unichem Laboratories、Neuland Laboratories Ltd.、Divi's Laboratories Limited 和 HIKAL Ltd. 等。

SKU-26988